Company
Invivyd, Inc.
Invivyd is a biopharmaceutical company that develops antibody-based therapies for serious viral infectious diseases.
Invivyd, Inc. is a publicly traded company. It trades under the ticker IVVD. Leadership tracked by CEOInsider includes Marc Elia (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Invivyd appointing Chairman Marc Elia as Chief Executive Officer amid board reshuffle, with the transition occurring as the company approaches Phase 3 trial data readouts for its COVID antibody candidate VYD2311. The new CEO received a substantial equity grant and severance arrangements tied to potential company sale valuations. Additionally, coverage has noted the company's widening losses and cash position as it moves toward these key trial results.
Summarized from the headlines in the sidebar; see each source for the full story.